Verition Fund Management
AUPH icon

Verition Fund Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Verition Fund Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,000
Closed -$229K – 2712
2021
Q4 		$229K Buy
+10,000
New +$237K ﹤0.01% 2161

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Verition Fund Management's AUPH Position: Q1 2026 in Review

Verition Fund Management sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2026, closing a stake of 29,314 shares — an estimated $468K sold.

Verition Fund Management first reported a position in AUPH in Q4 2019 and held it in 16 quarters. The position peaked at $4.12M in Q4 2021. 260 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

  • Verition Fund Management reported no remaining Aurinia Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 29,314 Aurinia Pharmaceuticals shares in Q1 2026, an estimated $468K.
  • Verition Fund Management first reported a position in Aurinia Pharmaceuticals in Q4 2019 and held it in 16 quarters.
  • Verition Fund Management's Aurinia Pharmaceuticals position peaked at $4.12M in Q4 2021.
  • 260 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.